Videos | Cardiogenic Shock
VIDEO: Cardiogenic Shock Initiative Continues to Reduce Mortality by 50 Percent

William Oโ€™Neill, M.D., medical director of the Center for Structural Heart Disease at Henry Ford Hospital, Detroit, explains data on first 250 patients in the National Cardiogenic Shock Initiative Study (NCSI) and new escalation protocols

Home October 08, 2019
Home
360 degree photo of a chronic total occlusion, CTO, case at Henry Ford Hospital in Detroit.
360 Photos | 360 View Photos
360 Degree View of a CTO Atherectomy Revascularization at Henry Ford Hospital

Henry Ford Hospital in Detroit gets a lot of referrals for very sick patients seeking a last resort treatment in its ...

Home October 08, 2019
Home
The life of Afib patient Glynn Crawford was saved three days after being prescribed a Zoll LifeVest wearable defibrillator by his cardiologist Barbara Williams, M.D., at University Hospitals Ahuja Medical CenterShe identified him as a high-risk for sudden cardiac arrest.
Feature | Sudden Cardiac Arrest
Sudden Cardiac Arrest Patient Walks to Ambulance Thanks to Wearable Defibrillator

October 7, 2019 โ€” Glynn Crawford was hospitalized at University Hospitals Ahuja Medical Center in late June/early July ...

Home October 07, 2019
Home
Heart MRI example. An example of a cardiac MRI exam showing perfusion defects in the heart muscle, amount of infarct and edema and a score for myocardial salvage which can help determine if revasularization will help restore heart function.
News | Magnetic Resonance Imaging (MRI)
Cardiac MRI Delivers Accurate Diagnosis for Frontline Chest Pain Evaluation

October 7, 2019 โ€“ A recent study published in the New England Journal of Medicine supports the use of cardiac magnetic ...

Home October 07, 2019
Home
Videos | TCT
VIDEO: SCAI Prospective on Key Takeaways at TCT 2019

Chandan Devireddy, M.D., offers insights about what he saw as the top take aways from the 2019 Transcatheter ...

Home October 04, 2019
Home
A Sapien 3 TAVR valve in position as seen under GE Assist guidance on angiography. Study Finds Sustained Benefit for TAVR vs. SAVR at One Year. #TCT2019 #TCT19
News | Heart Valve Technology
Study Finds Sustained Benefit for TAVR vs. SAVR at One Year

October 4, 2019 โ€“ A new analysis of the PARTNER 3 Trial data found a modest, but significant, improvement in one-year ...

Home October 04, 2019
Home
The COAPT Economic Analysis sub-study found it is cost effective to treat heart failure patients who have severe secondary mitral regurgitation with MitraClip to reduce their MR symptoms. #TMVR #TCT2019 #TCT19
News | Heart Failure
Transcatheter Mitral Valve Repair is Cost-Effective in Heart Failure Patients

October 4, 2019 โ€“ Results of a new economic analysis of the COAPT Trial data found that transcatheter mitral valve ...

Home October 04, 2019
Home
RenalGuard Therapy was found to be superior to the POSEIDON method in preventing contrast-induced acute kidney injury (CI-AKI) for patients with kidney disease who undergo interventional cath lab procedures. Results of the 700 patient, randomized, investigator-driven REMEDIAL III Trial presented at the 2019 Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. #TCT19 #TCT2019
News
Contrast-Induced Kidney Injury Prevented With RenalGuard in REMEDIAL III Trial

October 4, 2019 โ€“ RenalGuard Therapy was found to be superior to the POSEIDON method in preventing contrast-induced ...

Home October 04, 2019
Home
Five-year results from the PARTNER 2A Trial found patients with severe aortic stenosis (AS) and intermediate surgical risk who underwent Sapien 3 transcatheter aortic valve replacement (TAVR) had similar rates of death and disabling stroke compared to those who had surgical aortic valve replacement (SAVR). However, TAVR using a transthoracic approach had poorer outcomes compared to SAVR. #TCT2019
News | Heart Valve Technology
Similar Outcomes for TAVR vs. SAVR in Intermediate Surgical Risk Patients

October 3, 2019 โ€“ Five-year results from the PARTNER 2A Trial found patients with severe aortic stenosis (AS) and ...

Home October 03, 2019
Home
People watch the presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., live in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long term surgical outcomes. #TCT2019
Feature | Cath Lab
Left Main Treated With PCI or CABG Have Similar Outcomes at Five Years

October 3, 2019 โ€“ Five-year data from the EXCEL Trial showed patients with left main coronary disease treated with ...

Home October 03, 2019
Home
COAPT Trial three-year data show the MitraClip continued effectiveness in heart failure patients with secondary mitral reguritation. #TCT2019 #TCT19 #mitralclip
News | Heart Failure
COAPT Three-year Data Show Continued Effectiveness in Heart Failure Patients

October 3, 2019 โ€“ The three-year results from the COAPT Trial demonstrated that reducing severe secondary mitral ...

Home October 03, 2019
Home
The Boston Scientiofic Acurate Neo TAVR valve did not meet non-inferiority to the Sapien 3 valve in patients with severe aortic stenosis. #TAVR #TCT2019
News | Heart Valve Technology
New Acurate neo Self-expanding TAVR Device Does Not Meet Non-Inferiority Compared to Sapien 3

October 2, 2019 โ€“ The first randomized trial to compare the safety and efficacy of the new Boston Scientific Acurate neo ...

Home October 02, 2019
Home
Videos | University of Colorado Hospital
VIDEO: Overview of University of Colorado Structural Heart Program

Interview with John Carroll, M.D., director of interventional cardiology, Robert Quaife, M.D., director of advanced ...

Home October 02, 2019
Home
The Portico FDA investigational device exemption (IDE) study found that 30-day safety and one-year effectiveness outcomes of a novel self-expanding transcatheter aortic valve replacement (TAVR) system for patients with severe aortic stenosis (AS) at high or extreme-risk for surgery was noninferior to contemporary FDA-approved TAVR systems. #TAVR #TCT2019
News | Heart Valve Technology
Portico TAVR System Found Safe and Effective for High-Risk Surgical Patients

October 2, 2019 โ€“ The Abbott Portico FDA investigational device exemption (IDE) study found that 30-day safety and one ...

Home October 02, 2019
Home
Two Stents Implanted in Democratic Presidential Candidate Bernie Sanders, suffers chest pain
News | Cath Lab | Dave Fornell, Editor
Two Stents Implanted in Democratic Presidential Candidate Bernie Sanders

October 2, 2019 โ€” Democratic presidential candidate Sen. Bernie Sanders (D-VT) was hospitalized with chest pain on Oct ...

Home October 02, 2019
Home
ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now